Dawn of Targeted Therapy Using Claudin18.2 for Gastric Cancer

Dawn of Targeted Therapy Using Claudin18.2 for Gastric Cancer

In recent years, significant advancements in molecular biology have paved the way for novel targeted therapeutic strategies for gastric cancer treatment. Claudin18, which is an important structural protein involved in tight junctions between cells, and its subtype Claudin18.2 (CLDN18.2), which is sp...

Full description

Bibliographic Details
Main Authors: LI Hao, YE Xianhui, ZHOU Junjie, LI Xiaofen
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2023-10-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
cldn18.2
gastric cancer
targeted therapy
precision treatment
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.23.0164

Similar Items

Similar Items